Flynn James E → Oncorus, Inc.

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

38 filings by this filer

37 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other Filings by Flynn James E

Filed	Form	Issuer	Stake	Shares
2025-07-31	SCHEDULE	Larimar Therapeutics, Inc. LRMR	35.81%	30,667,474	view →
2025-03-24	SCHEDULE	ARS Pharmaceuticals, Inc. SPRY	10.72%	10,514,657	view →
2025-03-03	SCHEDULE	BiomX Inc. PHGE	9.99%	15,558,445	view →
2025-02-25	SCHEDULE	Singular Genomics Systems, Inc.	100.00%	1,000	view →
2025-01-28	SCHEDULE	Acutus Medical, Inc.	9.10%	5,492,725	view →
2025-01-23	SCHEDULE	Acutus Medical, Inc.	9.10%	9,705,857	view →
2024-07-11	SC	BiomX Inc. PHGE	—	—	view →
2024-05-30	SC	BiomX Inc. PHGE	—	—	view →
2023-05-23	SC	CalciMedica, Inc. CALC	—	—	view →
2023-03-17	SC	Larimar Therapeutics, Inc. LRMR	—	—	view →
2022-09-16	SC	Larimar Therapeutics, Inc. LRMR	—	—	view →
2022-07-05	SC	Acutus Medical, Inc.	—	—	view →
2022-04-27	SC	Acutus Medical, Inc.	—	—	view →
2021-11-19	SC	Oncology Institute, Inc. TOIIW	—	—	view →
2021-08-26	SC	Acutus Medical, Inc.	—	—	view →
2021-07-21	SC	Acutus Medical, Inc.	—	—	view →
2021-07-13	SC	Acutus Medical, Inc.	—	—	view →
2021-07-02	SC	Larimar Therapeutics, Inc. LRMR	—	—	view →
2021-07-01	SC	DFP HEALTHCARE ACQUISITIONS CORP. TOIIW	—	—	view →
2021-06-14	SC	Quantum-Si Inc QSIAW	—	—	view →

Showing 20 of 37

Flynn James E → Oncorus, Inc.

Item 4 — Purpose of Transaction

Cross-References

Other Filings by Flynn James E

Want this depth on every filing the moment it hits SEC EDGAR?